![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bt6138contents.gif)
Acta Cryst. (2002). E58, o644-o645 [ doi:10.1107/S1600536802008061 ]
Abstract: The title compound, C9H12N2O2, is the product of the second step in the synthesis of N-(4-amino-3-methoxyphenyl)methanesulfonamide, the side chain of an anticancer drug (viz. Amsacrine). The compound, obtained by the reduction of N-(2-methoxy-4-nitrophenyl)acetamide in EtOH with Pd/C as catalyst, under a hydrogen atmosphere, crystallizes from ethylacetoacetate.
Online 17 May 2002
Copyright © International Union of Crystallography
IUCr Webmaster